Bahrain vs Norway: Laboratories providing drug susceptibility testing (DST)
Bahrain
3.7
in 2012
Norway
2.9
in 2014
Bahrain rank
29th
Norway rank
32nd
Laboratories providing drug susceptibility testing (DST) over time
- Bahrain
- Norway
How they compare
Bahrain currently reports 3.7 against 2.9 in Norway, a difference of 0.8.
That makes Bahrain's figure about 1.3 times Norway's.
Across all 7 years both countries report, Bahrain has been ahead every year.
Bahrain ranks 29th and Norway ranks 32nd of 157 countries.
Bahrain has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bahrain | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.32 | 3.7 | 2.62 | Bahrain |
| 2010s | 3.83 | 3.03 | 0.8 | Bahrain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher laboratories providing drug susceptibility testing (dst), Bahrain or Norway?
- Bahrain, at 3.7 against 2.9 in Norway as of 2012.
- What is the difference in laboratories providing drug susceptibility testing (dst) between Bahrain and Norway?
- 0.8, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Norway?
- 7 years are reported by both, from 2005 to 2012.
- How do Bahrain and Norway rank globally for laboratories providing drug susceptibility testing (dst)?
- Bahrain ranks 29th and Norway ranks 32nd of 157 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Laboratories providing drug susceptibility testing (DST) (per 5 million population). Statizoid refreshes it automatically from the source and publishes the full history for both places.